- Sputnik International
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Argentina to Receive 25Mln Doses of Sputnik V Vaccine From Russia, President Says

© AP Photo / Juan MabromataWearing a mas to curb the spread of COVID-19, Argentine President Alberto Fernandez arrives for a press conference to announce that Argentina and Mexico will produce and distribute an experimental coronavirus vaccine, at the Olivos Presidential Residence in Olivos, Buenos Aires, Wednesday, August 12, 2020.
Wearing a mas to curb the spread of COVID-19, Argentine President Alberto Fernandez arrives for a press conference to announce that Argentina and Mexico will produce and distribute an experimental coronavirus vaccine, at the Olivos Presidential Residence in Olivos, Buenos Aires, Wednesday, August 12, 2020. - Sputnik International
Subscribe
BUENOS AIRES (Sputnik) - Argentina will receive 25 million doses of Russian vaccine against coronavirus Sputnik V in December and January, President Alberto Fernandez said in an interview with Sputnik.

"They will be able to provide us with 10 million doses, we will be able to have them in December, and in early January we could receive, as I was told, another 15 million doses," he said.

Fernandez also revealed that plans to get inoculated with a Russian coronavirus vaccine once it is available for people in his country.

RDIF CEO Kirill Dmitriev said on Monday that doses of Russian coronavirus vaccine for Argentina will be produced by the Russian Direct Investment Fund's (RDIF) partners in India, South Korea, China and some other countries.

"The Sputnik V vaccine for Argentina will be produced by RDIF partners in India, Korea, China and a number of other countries that are setting up a production of the Russian vaccine," Dmitriev said.

Earlier, the first deputy CEO of the Russian Direct Investment Fund, Anatoly Braverman, noted that Russia was seeing interest in more than 1.2 billion doses of its SPUTNIK V coronavirus vaccine, with about 200 million doses potentially going to Latin American countries.

Russia registered the world's first coronavirus vaccine, developed by the Gamaleya Institute, in August. The RDIF has been teaming up with partners to conduct Sputnik V clinical trials in Belarus, Venezuela and the United Arab Emirates.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала